Here is a thorough, textbook-backed explanation:
Why Lactulose is Given in Cirrhotic Patients
The short answer: to prevent and treat hepatic encephalopathy (HE) by lowering ammonia levels in the blood.
Background: The Problem in Cirrhosis
In healthy individuals, the liver clears ammonia from the portal blood before it can reach the brain. In cirrhosis, two things go wrong simultaneously:
- Reduced hepatocyte function - the diseased liver cannot metabolize ammonia efficiently.
- Portosystemic shunting - portal hypertension causes blood (and its ammonia load) to bypass the liver entirely through collateral vessels.
The result is arterial hyperammonemia, found in up to 90% of patients with HE. Ammonia crosses the blood-brain barrier, is taken up by the cerebellum and basal ganglia, causes astrocyte swelling, brain edema, and disrupts neurotransmission (especially via the GABA-benzodiazepine system) - producing symptoms ranging from subtle cognitive changes to frank coma.
HE develops in 50-70% of cirrhotic patients, and its occurrence carries a grim prognosis: 1-year survival of 42%, 3-year survival of only 23% without liver transplantation.
How Lactulose Works
Lactulose is a synthetic, non-absorbable disaccharide that is minimally absorbed into the bloodstream. It acts through several complementary mechanisms in the colon:
| Mechanism | Effect |
|---|
| Osmotic cathartic effect | Speeds gut transit, reducing time for ammonia-producing bacteria to act on nitrogenous substrates; expels ammonia-containing stool |
| Colonic acidification | Gut bacteria ferment lactulose primarily into lactic acid (and other organic acids), lowering colonic pH. At acidic pH, ammonia (NH3) is protonated to ammonium (NH4+), which is ionically trapped and cannot be absorbed across the gut wall |
| Inhibits urease-producing bacteria | The lower pH reduces the population of bacteria that generate ammonia from urea |
| Inhibits glutamine-dependent ammonia production | Directly inhibits ammonia synthesis in the gut wall |
The net result: blood ammonia levels can decrease by up to 50% with lactulose therapy.
Clinical Use
- Route: Oral (20 g in water/juice) or rectal enema (300 mL syrup in 700 mL water, retained 30 min) for patients who cannot swallow.
- Titration: Dose is adjusted to produce 2-3 soft stools per day - this is the practical endpoint used at bedside.
- First-line treatment for both overt and minimal hepatic encephalopathy.
- Given indefinitely to patients who have had an episode of overt HE to prevent recurrence.
Where Lactulose Fits in the Treatment Algorithm
Lactulose is first-line, but often combined with other agents:
- Rifaximin (minimally absorbed antibiotic) + lactulose is the preferred combination for HE prophylaxis and treatment. Studies show rifaximin + lactulose achieves complete reversal of HE in ~76% of patients vs ~44% with lactulose alone.
- Neomycin was historically used as second-line, but its ototoxicity and nephrotoxicity limit use.
- Liver transplantation remains the definitive treatment for cirrhosis and reverses HE.
Complications to Watch
Lactulose can cause:
- Hypovolemia (from excessive diarrhea)
- Hypernatremia (from free water losses)
- Abdominal cramping and bloating
These are avoided by careful dose titration to 2-3 stools/day rather than uncontrolled diarrhea.
Recent evidence note: A 2026 systematic review (
PMID 41767517) compared probiotics to lactulose for minimal HE in cirrhosis, suggesting probiotics may be an emerging alternative, though lactulose remains the established standard of care. Rifaximin meta-analyses (
PMID 39889173) continue to support its use alongside lactulose for prophylaxis.
Sources: Sleisenger and Fordtran's Gastrointestinal and Liver Disease; Tintinalli's Emergency Medicine; Symptom to Diagnosis: An Evidence-Based Guide, 4th ed.; Morgan & Mikhail's Clinical Anesthesiology, 7th ed.